Korean Journal of Clinical Oncology (대한종양외과학회지)

Korean Society of Surgical Oncology (대한종양외과학회)
권호 표지
DOI QR코드

DOI QR Code

Radiation segmentectomy for gastric leiomyosarcoma hepatic metastasis

  • Roh, Simon (Division of Interventional Radiology, St. Luke's University Health Network)
  • Received : 2018.11.18
  • Accepted : 2018.12.19
  • Published : 2018.12.31
⟨ Previous Next ⟩

Abstract

Metastases to the liver can be found in various malignancies, most commonly originating from the colon, rectum, pancreas, stomach, esophagus, breast, lung, and melanoma. Surgical resection of liver metastasis is generally considered to be the definitive therapy fore cure. However, many patients are unable to undergo surgical resection due to medical comorbidities or multifocal extent of malignant disease affecting the liver. Among patients not eligible for surgery, other therapies exist for treatment in order to down stage the disease for surgical resection or for palliation. Radioembolization of hepatic metastases has shown to improve outcomes among patients with variety of malignancies including more common malignancies such as colorectal cancer. Yttrium-90 (Y-90) radioembolization has been successfully used in the management of hepatic metastases. A small series of metastatic sarcoma to the liver treated with radioembolization showed a promising response. We report a case of metastatic gastric leiomyosarcoma to the liver treated with Y-90 glass microspheres therapy using the radiation segmentectomy approach, previously described for hepatocellular carcinoma.

Keywords

References

  1. Kennedy A, Cohn M, Coldwell DM, Drooz A, Ehrenwald E, Kaiser A, et al. Updated survival outcomes and analysis of long-term survivors from the MORE study on safety and efficacy of radioembolization in patients with unresectable colorectal cancer liver metastases. J Gastrointest Oncol 2017;8:614-24. https://doi.org/10.21037/jgo.2017.03.10
  2. Boas FE, Bodei L, Sofocleous CT. Radioembolization of colorectal liver metastases: indications, technique, and outcomes. J Nucl Med 2017;58(Suppl 2):104S-111S. https://doi.org/10.2967/jnumed.116.187229
  3. Bunck AC, Dos Santos DP, Chang DH, Reiser M, Pfister D, Bunck A, et al. Successful yttrium-90 microsphere radioembolization for hepatic metastases of prostate cancer. Case Rep Oncol 2017;10:627-33. https://doi.org/10.1159/000478004
  4. Jia Z, Jiang G, Zhu C, Wang K, Li S, Qin X. A systematic review of yttrium-90 radioembolization for unresectable liver metastases of melanoma. Eur J Radiol 2017;92:111-5. https://doi.org/10.1016/j.ejrad.2017.05.005
  5. Gordon AC, Uddin OM, Riaz A, Salem R, Lewandowski RJ. Making the case: intra-arterial therapy for less common metastases. Semin Intervent Radiol 2017;34:132-9. https://doi.org/10.1055/s-0037-1601852
  6. Venkatanarasimha N, Gogna A, Tong KT, Damodharan K, Chow PK, Lo RH, et al. Radioembolisation of hepatocellular carcinoma: a primer. Clin Radiol 2017;72:1002-13. https://doi.org/10.1016/j.crad.2017.07.021
  7. Vouche M, Habib A, Ward TJ, Kim E, Kulik L, Ganger D, et al. Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy. Hepatology 2014;60:192-201. https://doi.org/10.1002/hep.27057
  8. Riaz A, Gates VL, Atassi B, Lewandowski RJ, Mulcahy MF, Ryu RK, et al. Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization. Int J Radiat Oncol Biol Phys 2011;79:163-71. https://doi.org/10.1016/j.ijrobp.2009.10.062
  9. Keung EZ, Raut CP. Management of gastrointestinal stromal tumors. Surg Clin North Am 2017;97:437-52. https://doi.org/10.1016/j.suc.2016.12.001
  10. Rou WS, Ju JS, Kang SH, Moon HS, Sung JK, Lee BS, et al. A case of gastric leiomyosarcoma with multiple metastases. Korean J Gastroenterol 2015;65:112-7. https://doi.org/10.4166/kjg.2015.65.2.112
  11. Sideras PA, Sofocleous CT, Brody LA, Siegelbaum RH, Shah RP, Taskar NP. Superselective internal radiation with yttrium-90 microspheres in the management of a chemorefractory testicular liver metastasis. Cardiovasc Intervent Radiol 2012;35:426-9. https://doi.org/10.1007/s00270-011-0226-7
  12. Abstracts of the SIR 2015 Annual Scientific Meeting, February 28-March 5, 2015, Atlanta, GA. J Vasc Interv Radiol 2015;26(2 Suppl):S3-228. https://doi.org/10.1016/j.jvir.2014.12.025